Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
THE TRAVELERS INDEMNITY COMPANY et al v. CEPHALON, INC. et al
Case Number:
2:12-cv-04191
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
July 14, 2014
Cephalon Wins Dismissal Of Travelers' $22M Marketing Suit
A Pennsylvania federal judge on Monday dismissed Travelers Indemnity Co.'s suit seeking to recover $22 million in workers' compensation claims from Cephalon Inc. over the off-label use of two cancer painkillers, finding Travelers didn't allege an injury and thus did not have standing to sue.
-
September 17, 2013
Travelers Fights Cephalon Bid To Nix $22M Marketing Suit
The Travelers Indemnity Co. responded Tuesday to Cephalon Inc.'s efforts to dismiss a suit seeking to recover $22 million in workers' compensation claims over the off-label use of two cancer painkillers, claiming that Cephalon is attempting to diminish the significance of its fraud accusations.
-
July 24, 2012
Travelers Sues Cephalon Over $17M In Actiq Claims
Travelers Companies Inc. on Tuesday fired back at Teva Pharmaceutical Industries Ltd. unit Cephalon Inc. in the insurer's fight to recover $17.5 million in paid workers' compensation claims, accusing the companies of deceptively pedaling off-label uses of a cancer painkiller to boost profits.